Clinical Trial Update: Contegra Versus Pulmonary Homograft for Right Ventricular Outflow Tract Reconstruction in Newborns

View source ↗

Summary

A completed clinical trial comparing Contegra bovine jugular vein conduit to pulmonary homograft for right ventricular outflow tract reconstruction in newborns.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Defect

Drugs mentioned

• Contegra (bovine jugular vein conduit)
• Pulmonary homograft (pulmonary artery homograft)

Snippet

Sponsor: Queen Fabiola Children's University Hospital | Conditions: Congenital Heart Defect, Right Ventricular Outflow Tract Reconstruction | Status: COMPLETED